JUGAAD Competitors

Jain Irrigation Systems Limited (JISL) having more than 11,000 associates worldwide and revenues of $1.2 billion, is an Indian multinational company with manufacturing plants in 32 locations across the globe. It is engaged in manufacturing of Micro Irrigation Systems, PVC & HDPE Piping systems, Plastic Sheets, Agro Processed Products, Renewable Energy Solutions, Tissue Culture Plants, Automation & Precision Farming, Financial Services and other agricultural inputs over the last 38+ years. It has pioneered a silent revolution with modern irrigation systems and innovative technologies in order to save precious water and has helped to get significant increase in crop yields, especially for millions of small farmers across the globe. It has also ushered in the new concept of large scale Integrated Irrigation Projects (IIP). All the products & services of JISL help create sustainable future while fulfilling it’s vision ‘Leave this world better than you found it’. Jain Irrigation is the only Indian company to be in the list of "Companies that Changed the World" compiled for the first time in 2015 by Fortune. It was 7th in the World from the list of 51. JISL is listed in NSE-Mumbai at JISL.JALEQS and in BSE at code 50029. Please visit us at www.jains.com ; Call us on 1800-599-5000 ; WhatsApp us on +91 9422776699

Jiva Ayurveda, founded in 1992, is a leading Ayurvedic healthcare organization with a vision to create a healthier and happier society. Under the visionary leadership of Dr. Partap Chauhan, a world-famous Ayurvedacharya, Jiva has been at the forefront of delivering personalised, root-cause-based treatments through its extensive network of over 80 clinics across India, the world’s first and largest Ayurvedic telemedicine center, Jivagram hospital, and affiliates in over 50 countries across the globe. Jiva operates across multiple business verticals including treatments, e-commerce, Jiva Public School, and a manufacturing unit, demonstrating its commitment to holistic well-being. With more than three decades of data-driven research and the use of technology, Jiva has developed a unique treatment approach, ‘Ayunique™’, that focuses on Personalised Ayurveda Care through clinical excellence. This approach is guided by a team of highly qualified Ayurveda practitioners who have successfully integrated traditional wisdom with modern medical advancements. Jiva is the first organization to have championed a protocol and data-driven diagnosis and treatment. In Products, Jiva promotes a wide range of 200+ Ayurvedic products (healthcare & beauty care) through its online channel. Jiva has an International division that offers Ayurvedic courses, treatments, and consultations to hundreds of people through its partners outside India. It also runs a GMP-certified Pharmacy that manufactures a wide range of 800+ herbal cosmetics and Ayurvedic medicinal/OTC products. Fostering a work environment that empowers employees to thrive, Jiva's company culture is built on mutual respect and empathy; actively promoting team spirit, celebrating successes, and investing in employee well-being. Recognized for its innovation and leadership, Jiva has been the recipient of numerous national & international accolades, including the UN’s World Summit Award for its TeleDoc project.

CureMetrix is committed to the advancement of technology that improves disease detection and survival rates worldwide. Our AI-based products and research are focused on leveraging artificial intelligence and deep learning to develop the next generation of medical image analysis technology that radiologists and patients can confidently rely on. Today, our powerful image analysis platform is an adjunct, precision tool for mammography. Our goal is to equip radiologists with the objective, data-driven answers they need to support patients and their healthcare team as they make decisions about their health. At CureMetrix, we believe that providing radiologists with the most advanced technology to support their evaluation of mammograms will lead to improved clinical outcomes, reduced healthcare costs, and increased assurance that patients are getting the highest standard of care available from screening. Over the last 10 years since our founding in 2014, we have focused on building products with extremely high efficacy that are easy to install, operate within existing clinical workflows, and minimize extra steps from radiologists and patients. CureMetrix has partnered with practicing radiologists, cardiologists, and esteemed institutions around the world to collect over 5 million images to train and validate our algorithms. From breast cancer to heart disease to kidney disease we believe that AI can be used to improve outcomes for patients and extend the impact and value of screening programs globally.